{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:36:47Z","timestamp":1789576607491,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.isci.2026.116500","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:01:59Z","timestamp":1782237719000},"page":"116500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The CD49b (ITGA2) collagen receptor excludes CD8+ T cell infiltration in pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9454-6327","authenticated-orcid":false,"given":"Ibrahim Ragab","family":"Eissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve M.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Sharova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116500_bib1","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1158\/1078-0432.CCR-14-1051","article-title":"Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer","volume":"21","author":"Whatcott","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116500_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","article-title":"Pancreatic cancer stroma: an update on therapeutic targeting strategies","volume":"17","author":"Hosein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2026.116500_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15095","article-title":"Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer","volume":"8","author":"Carstens","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116500_bib4","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1053\/j.gastro.2013.07.025","article-title":"Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma","volume":"145","author":"Ene\u2013Obong","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2026.116500_bib5","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s12029-024-01078-8","article-title":"The Current Landscape of Clinical Trials for Immunotherapy in Pancreatic Cancer: A State-of-the-Art Review","volume":"55","author":"Sarfraz","year":"2024","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.isci.2026.116500_bib6","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1158\/1078-0432.CCR-21-3452","article-title":"Facts and hopes in immunotherapy of pancreatic cancer","volume":"28","author":"Bockorny","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116500_bib7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/jamaoncol.2019.1588","article-title":"Durvalumab with or without tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: a phase 2 randomized clinical trial","volume":"5","author":"O\u2019Reilly","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.isci.2026.116500_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ctrv.2019.06.005","article-title":"Checkpoint inhibitors in pancreatic cancer","volume":"78","author":"Henriksen","year":"2019","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.isci.2026.116500_bib9","doi-asserted-by":"crossref","first-page":"19609","DOI":"10.1073\/pnas.1908626116","article-title":"Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells","volume":"116","author":"Tian","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.116500_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2017.01.041","article-title":"Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology","volume":"392","author":"Zhan","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2026.116500_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","article-title":"Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma","volume":"21","author":"Provenzano","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116500_bib12","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.116500_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biomaterials.2016.06.048","article-title":"Cyclopamine disrupts tumor extracellular matrix and improves the distribution and efficacy of nanotherapeutics in pancreatic cancer","volume":"103","author":"Zhang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.isci.2026.116500_bib14","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1200\/JCO.2015.62.8719","article-title":"Randomized Phase Ib\/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer","volume":"33","author":"Catenacci","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116500_bib15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41416-019-0683-3","article-title":"Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma","volume":"122","author":"De Jesus-Acosta","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2026.116500_bib16","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1158\/1078-0432.CCR-14-1269","article-title":"Pilot clinical trial of hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinoma","volume":"20","author":"Kim","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116500_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116500_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/gutjnl-2020-322744","article-title":"Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism","volume":"71","author":"Sun","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.isci.2026.116500_bib19","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1158\/0008-5472.CAN-07-5714","article-title":"Cancer-associated stromal fibroblasts promote pancreatic tumor progression","volume":"68","author":"Hwang","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.116500_bib20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","article-title":"CD10+ GPR77+ cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116500_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/gutjnl-2016-311954","article-title":"Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer","volume":"67","author":"Hessmann","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.isci.2026.116500_bib22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41419-021-03574-2","article-title":"Cancer-associated fibroblasts-mediated ATF4 expression promotes malignancy and gemcitabine resistance in pancreatic cancer via the TGF-\u03b21\/SMAD2\/3 pathway and ABCC1 transactivation","volume":"12","author":"Wei","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.116500_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao0475","article-title":"Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials","volume":"10","author":"Lampi","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.116500_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.791453","article-title":"Immune modulatory properties of collagen in cancer","volume":"12","author":"R\u00f8mer","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116500_bib25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116500_bib26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in \u03b1SMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116500_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.matbio.2006.10.007","article-title":"Mammalian collagen receptors","volume":"26","author":"Leitinger","year":"2007","journal-title":"Matrix Biol."},{"key":"10.1016\/j.isci.2026.116500_bib28","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.biocel.2003.08.016","article-title":"The collagen receptor subfamily of the integrins","volume":"36","author":"White","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.isci.2026.116500_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fphy.2017.00012","article-title":"Collagen type I as a ligand for receptor-mediated signaling","volume":"5","author":"Boraschi-Diaz","year":"2017","journal-title":"Front. Phys."},{"key":"10.1016\/j.isci.2026.116500_bib30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116500_bib31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the cancer cell line encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116500_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2022-327927","article-title":"FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer","volume":"73","author":"Canel","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.isci.2026.116500_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13046-022-02286-5","article-title":"Overexpressed integrin alpha 2 inhibits the activation of the transforming growth factor \u03b2 pathway in pancreatic cancer via the TFCP2-SMAD2 axis","volume":"41","author":"Cai","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116500_bib34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/s13046-019-1496-1","article-title":"Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway","volume":"38","author":"Ren","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116500_bib35","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/ijc.28765","article-title":"Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling","volume":"135","author":"Nones","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.isci.2026.116500_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.humgen.2024.201358","article-title":"Upregulated expression of DDR2 and MYLK correlates with poor prognosis in colorectal tumours","volume":"43","author":"Avanthi","year":"2025","journal-title":"Hum. Gene"},{"key":"10.1016\/j.isci.2026.116500_bib37","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/path.4415","article-title":"Discoidin domain receptor 2 ( DDR2 ) promotes breast cancer cell metastasis and the mechanism implicates epithelial\u2013mesenchymal transition programme under hypoxia","volume":"234","author":"Ren","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.isci.2026.116500_bib38","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1053\/j.gastro.2006.09.007","article-title":"Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors","volume":"131","author":"Couvelard","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2026.116500_bib39","doi-asserted-by":"crossref","first-page":"12114","DOI":"10.1074\/jbc.M112.409599","article-title":"Shedding of discoidin domain receptor 1 by membrane-type matrix metalloproteinases","volume":"288","author":"Fu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.116500_bib40","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.25716","article-title":"Collagen induces activation of DDR1 through lateral dimer association and phosphorylation between dimers","volume":"6","author":"Juskaite","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.isci.2026.116500_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103975","article-title":"DDR1-targeted therapies: current limitations and future potential","volume":"29","author":"Wu","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.isci.2026.116500_bib42","first-page":"5403","article-title":"High beta integrin expression is differentially associated with worsened pancreatic ductal adenocarcinoma outcomes","volume":"12","author":"Benesch","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.isci.2026.116500_bib43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","article-title":"Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion","volume":"599","author":"Sun","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116500_bib44","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1038\/ncomms8458","article-title":"Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints","volume":"6","author":"Mikucki","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116500_bib45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116500_bib46","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4049\/jimmunol.1300344","article-title":"Synergistic expression of the CXCL10 gene in response to IL-1\u03b2 and IFN-\u03b3 involves NF-\u03baB, phosphorylation of STAT1 at Tyr701, and acetylation of histones H3 and H4","volume":"191","author":"Burke","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.116500_bib47","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm.4123","article-title":"Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy","volume":"22","author":"Jiang","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.116500_bib48","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.isci.2026.116500_bib49","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.116500_bib50","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.116500_bib51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nm.4082","article-title":"Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression","volume":"22","author":"Laklai","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.116500_bib52","doi-asserted-by":"crossref","first-page":"C64","DOI":"10.1158\/1535-7163.TARG-11-C64","article-title":"Abstract C64: Antitumor activity of GBR 500, a monoclonal VLA-2 antibody","volume":"10","author":"Hou","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.isci.2026.116500_bib53","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2011-LB-294","article-title":"Abstract LB-294: GBR 500, a monoclonal VLA-2 antibody inhibits tumor and metastasis growth but not extravasation in a prostate cancer animal model","volume":"71","author":"Attinger","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.116500_bib54","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0016-5085(98)70209-4","article-title":"Identification, culture, and characterization of pancreatic stellate cells in rats and humans","volume":"115","author":"Bachem","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2026.116500_bib55","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.19.1.016007","article-title":"Computational segmentation of collagen fibers from second-harmonic generation images of breast cancer","volume":"19","author":"Bredfeldt","year":"2014","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.isci.2026.116500_bib56","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1158\/0008-5472.CAN-24-2346","article-title":"spatialGE Is a User-Friendly Web Application That Facilitates Spatial Transcriptomics Data Analysis","volume":"85","author":"Ospina","year":"2025","journal-title":"Cancer Res."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226018754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226018754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:21:48Z","timestamp":1788225708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226018754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2589004226018754"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116500","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The CD49b (ITGA2) collagen receptor excludes CD8+ T cell infiltration in pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116500"}}